Evidence map›Paper›PMID 36425532›Full record

ArticleFrontiers in cell and developmental biology2022

Vitronectin-based hydrogels recapitulate neuroblastoma growth conditions.

Ezequiel Monferrer, Oana Dobre, Sara Trujillo, Mariana Azevedo González Oliva, Alexandre Trubert-Paneli, Delia Acevedo-León, Rosa Noguera, Manuel Salmeron-Sanchez

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Ezequiel MonferrerDepartment of Pathology Medical School, University of Valencia-INCLIVA Biomedical Health Research Institute, Valencia, Spain.
Oana DobreCentre for the Cellular Microenvironment, Advanced Research Centre, University of Glasgow, Glasgow, United Kingdom.
Sara TrujilloINM-Leibniz Institute for New Materials, Saarbrücken, Germany.
Mariana Azevedo González OlivaCentre for the Cellular Microenvironment, Advanced Research Centre, University of Glasgow, Glasgow, United Kingdom.
Alexandre Trubert-PaneliCentre for the Cellular Microenvironment, Advanced Research Centre, University of Glasgow, Glasgow, United Kingdom.
Delia Acevedo-LeónClinical Analysis Service, Hospital Universitario Dr. Peset, Valencia, Spain.
Rosa NogueraDepartment of Pathology Medical School, University of Valencia-INCLIVA Biomedical Health Research Institute, Valencia, Spain.
Manuel Salmeron-SanchezCentre for the Cellular Microenvironment, Advanced Research Centre, University of Glasgow, Glasgow, United Kingdom.
University of Glasgow · GBCentro de Investigación Biomédica en Red de Cáncer · ESHospital Universitario Doctor Peset · ESINCLIVA Health Research Institute · ESLeibniz-Institute for New Materials · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The tumor microenvironment plays an important role in cancer development and the use of 3D

Indexed as

digital image analysisextracellular matrixneuroblastomapolyethylene-glycolstiffnessvitronectin

Identifiers

PMID36425532
PMCPMC9679952
OpenAlexW4304183653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.